liarozole has been researched along with Benign Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kris, MG; Miller, VA; Muindi, JR; Rigas, JR; Tong, WP; Venkatraman, E; Warrell, RP | 1 |
| Miller, WH | 1 |
| Lotan, R | 1 |
1 review(s) available for liarozole and Benign Neoplasms
| Article | Year |
|---|---|
The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer.
Topics: Antineoplastic Agents; Cell Differentiation; Chemoprevention; Cytochrome P-450 Enzyme Inhibitors; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Imidazoles; Neoplasms; Phenotype; Receptors, Retinoic Acid; Retinoids; Tretinoin | 1998 |
1 trial(s) available for liarozole and Benign Neoplasms
| Article | Year |
|---|---|
Modulation of all-trans retinoic acid pharmacokinetics by liarozole.
Topics: Antineoplastic Agents; Humans; Imidazoles; Neoplasms; Tretinoin | 1994 |
1 other study(ies) available for liarozole and Benign Neoplasms
| Article | Year |
|---|---|
Are we ready to use surrogate end points and surrogate tissues to evaluate response to chemopreventive and therapeutic intervention?
Topics: Antineoplastic Agents, Hormonal; Biomarkers; Biopsy; Clinical Trials as Topic; Health Services Research; Humans; Imidazoles; Mouth; Mucous Membrane; Neoplasms; Treatment Outcome; Tretinoin | 2000 |